Table 4.
Diagnostic accuracy of multiparametric MRI, ELF and TE in detecting clinically significant liver disease, with and without post-liver transplant patients included.
Normal + simple steatosis | Inflammation and/or fibrosis | AUROC (95% CI) | p-value | Diagnostic test failure rate | ||
---|---|---|---|---|---|---|
All patients | cT1/LIF | 23 | 119 | 0.76 (0.66–0.88) | < 0.001 | 4.3% |
ELF | 23 | 124 | 0.80 (0.72–0.89) | < 0.001 | 1.9% | |
TE | 21 | 104 | 0.83 (0.74–0.91) | < 0.001 | 15% | |
Excluding post-transplant | cT1/LIF | 13 | 89 | 0.89 (0.83–0.95) | < 0.001 | 6.1% |
ELF | 19 | 94 | 0.77 (0.67–0.88) | < 0.001 | 1.7% | |
TE | 17 | 79 | 0.85 (0.76–0.93) | < 0.001 | 16.5% |